These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20066167)

  • 61. Bacillus Calmette-Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections.
    Larsen ES; Joensen UN; Poulsen AM; Goletti D; Johansen IS
    APMIS; 2020 Feb; 128(2):92-103. PubMed ID: 31755155
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
    Fujita N; Hatakeyama S; Momota M; Kido K; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2020 Aug; 38(8):684.e17-684.e24. PubMed ID: 32278732
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors.
    Lüftenegger W; Ackermann DK; Futterlieb A; Kraft R; Minder CE; Nadelhaft P; Studer UE
    J Urol; 1996 Feb; 155(2):483-7. PubMed ID: 8558641
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Failed endovascular abdominal aortic aneurysm repair due to
    Nishizawa M; Kudo T; Kijima T; Fujii Y
    J Vasc Surg Cases Innov Tech; 2022 Dec; 8(4):807-812. PubMed ID: 36507086
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model.
    Erdoğar N; Iskit AB; Eroğlu H; Sargon MF; Mungan NA; Bilensoy E
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10156-64. PubMed ID: 26682462
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Jain H; Gada K; Zaidi S; Asiago-Reddy E; Eranki A
    Proc (Bayl Univ Med Cent); 2019 Oct; 32(4):577-578. PubMed ID: 31656426
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ENDOPHTHALMITIS IN A PATIENT TREATED WITH BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY.
    Vadboncoeur J; Olivier S; Soualhine H; Labbé AC; Bélair ML
    Retin Cases Brief Rep; 2018 Fall; 12(4):326-330. PubMed ID: 27893591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report.
    Duvnjak P; Laguna M
    J Radiol Case Rep; 2016 Aug; 10(8):12-27. PubMed ID: 27761190
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.
    Hudson MA; Yuan JJ; Catalona WJ; Ratliff TL
    J Urol; 1990 Dec; 144(6):1362-4. PubMed ID: 2231927
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
    Cadiou S; Al Tabaa O; Nguyen CD; Faccin M; Guillin R; Revest M; Guggenbuhl P; Houvenagel E; Pertuiset E; Coiffier G
    Clin Rheumatol; 2019 Jun; 38(6):1773-1783. PubMed ID: 30868320
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW; Shen ZJ; Ding GQ
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multi-organ failure with atypical liver granulomas following intravesical Bacillus Calmette-Guerin instillation.
    Kaklamanos M; Hardavella G; Trigidou R; Dionellis G; Paissios N; Koulouris N; Goritsas C
    World J Hepatol; 2011 Mar; 3(3):79-82. PubMed ID: 21487539
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bone marrow infection with bacillus Calmette-Guérin (BCG) after intravesical immunotherapy.
    Nemeth J; Stoiser B; Winkler HM; Müllauer L; Graninger W; Winkler S
    Wien Klin Wochenschr; 2008; 120(3-4):121-3. PubMed ID: 18322775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Systemic BCG-osis following intravesical BCG instillation for bladder carcinoma.
    Liaw F; Tan YY; Hendry D
    Clin Case Rep; 2017 Oct; 5(10):1569-1572. PubMed ID: 29026546
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Growth inhibition of HeLa cell by internalization of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) Tokyo.
    Kitamura A; Mastumoto S; Asahina I
    Cancer Cell Int; 2009 Dec; 9():30. PubMed ID: 19954548
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.
    McParland C; Cotton DJ; Gowda KS; Hoeppner VH; Martin WT; Weckworth PF
    Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1330-3. PubMed ID: 1443892
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Two-stage posterior decompression and fusion for tuberculous spondylitis after intravesical bacillus Calmette-Guerin instillation.
    Ohata H; Prakasa D; Goto H; Ohata K; Goto T; Nishikawa M
    J Craniovertebr Junction Spine; 2021; 12(3):318-321. PubMed ID: 34729001
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer.
    Liu Y; Lu J; Huang Y; Ma L
    J Oncol; 2019; 2019():6230409. PubMed ID: 30984262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.